Enter assignee name

EPO Patents = 4

Trademarks = 1

Forward Citations = 2

Loading Chart...

14 inventors (with patents filed for the assignee):

David Thomas Davies (7 out of 7 patents)

Simon Leiris (6 out of 6 patents)

Nicolas Sprynski (4 out of 4 patents)

4. Martin Everett (4 out of 4 patents)

5. Thomas David Pallin (4 out of 30 patents)

6. Andrew Peter Cridland (3 out of 3 patents)

7. Lilha Beyria (3 out of 3 patents)

8. David Edward Clark (3 out of 26 patents)

9. Richard Leonard Elliott (3 out of 16 patents)

10. Toby Jonathan Blench (3 out of 11 patents)

11. Jonathan Mark Sutton (1 out of 33 patents)

12. Magdalena Zalacain (1 out of 45 patents)

13. Michael Steven Bodnarchuk (1 out of 1 patent)

14. Marc Lemonnier (1 out of 1 patent)

15. David Pallin (0 patent)

7 patents: Sort by Forward Citations

1. 12378244 - Diazabicyclooctanones as inhibitors of serine β-lactamases (2025-08-05),

2. 12286411 - Indane derivatives for use in the treatment of bacterial infection (2025-04-29),

3. 12247013 - Indane derivatives for use in the treatment of bacterial infection (2025-03-11),

4. 11905286 - Diazabicyclooctanones as inhibitors of serine beta-lactamases (2024-02-20),

5. 11299467 - Chemical compounds (2022-04-12),

6. 11000511 - Chemical compounds as antibiotics (2021-05-11),

7. 9914712 - Antibacterial thiazolecarboxylic acids (2018-03-13),

Antabio is a biopharmaceutical company focused on the development of novel antibacterial treatments. The company's innovative approach targets drug-resistant bacterial infections, providing new treatment options for patients. Antabio's pipeline includes promising candidates for multiple indications, with a strong emphasis on addressing the global health threat of antibiotic resistance.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

7 Patents

#3 in Labege

#2,182 in France

Labege, France

Antabio Sas